Breaking News Instant updates and real-time market news.

PRNB

Principia Biopharma

$29.86

-0.18 (-0.60%)

16:03
05/07/19
05/07
16:03
05/07/19
16:03

Principia Biopharma reports Q1 EPS (57c), consensus (62c)

Reports Q1 revenue $5.16M, consensus $1.9M. "In 2019, we are focused on executing our value-creating clinical development initiatives, including enrollment of our global Phase 3 trial in patients with pemphigus, the release of top-line PRN1008 data from a Phase 2 clinical trial in immune thrombocytopenia (ITP) and a Phase 2 extension trial in pemphigus vulgaris," said Martin Babler, president and chief executive officer of Principia. "We started this year with a presentation of our Phase 2 clinical trial, the Believe-PV study, for PRN1008 as part of the Late-breaking Research: Clinical Trials program at the American Academy of Dermatology (AAD) annual meeting in Washington D.C. In addition, we have appointed industry veteran Shao-Lee Lin to our Board of Directors and have reacquired the rights to our oral immunoproteasome program from AbbVie."

PRNB Principia Biopharma
$29.86

-0.18 (-0.60%)

10/09/18
BARD
10/09/18
INITIATION
Target $50
BARD
Outperform
Principia Biopharma initiated with an Outperform at Baird
Baird analyst Brian Skorney started Principia Biopharma (PRNB) with an Outperform rating and $50 price target, stating that its BTK inhibitor partnered with Sanofi (SNY) for multiple sclerosis has blockbuster potential. He also believes PRN1008, which is entering Phase 3, has a worldwide opportunity over $500M in pemphigus that would also open the door for a host of other indications.
04/16/19
STFL
04/16/19
INITIATION
Target $45
STFL
Buy
Principia Biopharma initiated with a Buy at Stifel
Stifel analyst Derek Archila initiated Principia Biopharma with a Buy and $45 price target.
04/16/19
STFL
04/16/19
INITIATION
Target $45
STFL
Buy
Stifel starts Principia at Buy ahead of 'catalyst rich' Q4
Stifel analyst Derek Archila initiated coverage of Principia Biopharma with a Buy rating and $45 price target. The analyst is "bullish" on the shares ahead of a "catalyst rich" Q4. The company's lead asset PRN1008, a BTK inhibitor, should become "further de-risked" in two beachhead autoimmune/inflammatory conditions, pemphigus vulgaris and immune thrombocytopenia purpura, in Q4, Archila tells investors in a research note. The analyst thinks the Street does not fully appreciate the nuances of PRN1008's molecular design, which he believes will allow for improved safety and efficacy in autoimmune/inflammatory conditions.
04/17/19
04/17/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Organogenesis (ORGO) initiated with an Outperform at Oppenheimer. 2. Teladoc (TDOC) initiated with an Overweight at Stephens. 3. Solar Capital (SLRC) initiated with an Outperform at Raymond James. 4. Principia Biopharma (PRNB) initiated with a Buy at Stifel. 5. Aurora Cannabis (ACB), HEXO Corp (HEXO), Canopy Growth (CGC), and Performance Food Group (PFGC) initiated with a Buy at BofA/Merrill while Cronos Group (CRON) was initiated with an Underperform at BofA/Merrill. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

KRYS

Krystal Biotech

$32.05

-0.27 (-0.84%)

09:31
05/24/19
05/24
09:31
05/24/19
09:31
Recommendations
Krystal Biotech analyst commentary  »

Krystal Biotech price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

SNAP

Snap

$11.13

-0.2 (-1.77%)

, VIVHY

Vivendi

$0.00

(0.00%)

09:31
05/24/19
05/24
09:31
05/24/19
09:31
Periodicals
Snapchat want to let users add music to posts, WSJ says »

Anne Steele and Georgia…

SNAP

Snap

$11.13

-0.2 (-1.77%)

VIVHY

Vivendi

$0.00

(0.00%)

SNE

Sony

$48.36

-2.13 (-4.22%)

FB

Facebook

$180.89

-4.36 (-2.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 30

    May

  • 03

    Jun

  • 03

    Jun

  • 10

    Jun

ARMK

Aramark

$31.18

-0.63 (-1.98%)

09:30
05/24/19
05/24
09:30
05/24/19
09:30
Conference/Events
Aramark management to meet with JPMorgan »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

SINA

Sina

$42.56

-4.94 (-10.40%)

, WB

Weibo

$45.40

-5.85 (-11.41%)

09:29
05/24/19
05/24
09:29
05/24/19
09:29
Recommendations
Sina, Weibo analyst commentary  »

Sina, Weibo price targets…

SINA

Sina

$42.56

-4.94 (-10.40%)

WB

Weibo

$45.40

-5.85 (-11.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPRO

GoPro

$7.15

-0.1 (-1.38%)

09:28
05/24/19
05/24
09:28
05/24/19
09:28
Hot Stocks
GoPro expands Trade-Up program to countries in European Union »

GoPro announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

RVLT

Revolution Lighting

$0.18

0.004 (2.34%)

09:28
05/24/19
05/24
09:28
05/24/19
09:28
Hot Stocks
Revolution Lighting receives stay of delisting from Nasdaq »

Revolution Lighting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VSAT

ViaSat

$87.89

-1.63 (-1.82%)

09:26
05/24/19
05/24
09:26
05/24/19
09:26
Recommendations
ViaSat analyst commentary  »

ViaSat price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FL

Foot Locker

$52.85

-1.355 (-2.50%)

09:26
05/24/19
05/24
09:26
05/24/19
09:26
Hot Stocks
Foot Locker still expects to open over a dozen Power stores in 2019 »

Says on track to open 15…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 09

    Jul

KTB

Kontoor Brands

$38.51

0.82 (2.18%)

09:25
05/24/19
05/24
09:25
05/24/19
09:25
Initiation
Kontoor Brands initiated  »

Kontoor Brands initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:25
05/24/19
05/24
09:25
05/24/19
09:25
General news
The April U.S. durables report »

The April U.S. durables…

09:25
05/24/19
05/24
09:25
05/24/19
09:25
Conference/Events
Helsinki Commission and House Financial Services Committee holds briefing »

The Helsinki Commission…

ANTM

Anthem

$277.80

-5.16 (-1.82%)

09:25
05/24/19
05/24
09:25
05/24/19
09:25
Conference/Events
Anthem participates in a conference call with JPMorgan »

Managed Care/Facilities…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 29

    May

QGEN

Qiagen

$38.48

-0.235 (-0.61%)

09:25
05/24/19
05/24
09:25
05/24/19
09:25
Conference/Events
Qiagen participates in a conference call with JPMorgan »

Life Science &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 31

    May

  • 20

    Jun

  • 06

    Aug

EVOP

EVO Payments

$27.74

-0.75 (-2.63%)

09:24
05/24/19
05/24
09:24
05/24/19
09:24
Initiation
EVO Payments initiated  »

EVO Payments initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 05

    Jun

  • 11

    Jun

TSS

TSYS

$99.61

-1.62 (-1.60%)

, GPN

Global Payments

$147.97

-2.64 (-1.75%)

09:24
05/24/19
05/24
09:24
05/24/19
09:24
Hot Stocks
Breaking Hot Stocks news story on TSYS, Global Payments »

TSYS jumps 7% to $107.00…

TSS

TSYS

$99.61

-1.62 (-1.60%)

GPN

Global Payments

$147.97

-2.64 (-1.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

  • 05

    Jun

  • 13

    Nov

CPRT

Copart

$69.99

5 (7.69%)

09:21
05/24/19
05/24
09:21
05/24/19
09:21
Recommendations
Copart analyst commentary  »

Copart price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

SPX

S&P 500

$0.00

(0.00%)

, VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

09:18
05/24/19
05/24
09:18
05/24/19
09:18
Options
Overnight activity included 434 trades in SPX and 55 trades in VIX »

434 trades were executed…

SPX

S&P 500

$0.00

(0.00%)

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FL

Foot Locker

$52.85

-1.355 (-2.50%)

09:17
05/24/19
05/24
09:17
05/24/19
09:17
Hot Stocks
Foot Locker sees low-to-mid single digit comp gain in Q2 »

Says inventory remains…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 09

    Jul

FSV

FirstService

$93.59

7.5 (8.71%)

09:16
05/24/19
05/24
09:16
05/24/19
09:16
Recommendations
FirstService analyst commentary  »

FirstService price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

MCK

McKesson

$129.11

-0.48 (-0.37%)

09:15
05/24/19
05/24
09:15
05/24/19
09:15
Conference/Events
McKesson participates in a conference call with JPMorgan »

Healthcare Technology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 31

    May

FL

Foot Locker

$52.85

-1.355 (-2.50%)

09:14
05/24/19
05/24
09:14
05/24/19
09:14
Hot Stocks
Foot Locker intends to continue to implement $1.2B share repurchase program »

Says intends to continue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 09

    Jul

FG

FGL Holdings

$8.54

-0.27 (-3.06%)

09:13
05/24/19
05/24
09:13
05/24/19
09:13
Conference/Events
FGL Holdings participates in a conference call with JPMorgan »

Life Insurance Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QRVO

Qorvo

$60.68

0.47 (0.78%)

09:13
05/24/19
05/24
09:13
05/24/19
09:13
Recommendations
Qorvo analyst commentary  »

Qorvo price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FL

Foot Locker

$52.85

-1.355 (-2.50%)

09:11
05/24/19
05/24
09:11
05/24/19
09:11
Hot Stocks
Foot Locker says focused on a 'more premium apparel strategy' »

Says 2019 has gotten over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 09

    Jul

HOLX

Hologic

$44.70

-0.29 (-0.64%)

09:07
05/24/19
05/24
09:07
05/24/19
09:07
Conference/Events
Hologic participates in a conference call with JPMorgan »

Life Science &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 05

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.